The testing kit is currently not on the local market. ANSA McAl Inc however made a donation of 100 MIA BY XYTOTEST MOLECULAR Screening Test Kits for HPV to Dr. Latoya Gooding. Dr. Gooding is expected to conduct a study in the coming weeks.
Dr. Gooding in her remarks said, “I am ecstatic about these kits is just not a test for women, but it allows them to be in the comfort of their own home, all the women have to do is to get the test done and mail it back.”
The oncologist highlighted, “that applicator when it enters the vagina starts to collect cells until it reaches the Cervix and even though women who might not get to reach to the back of the cervix, the applicator would have collect enough cells for testing.”
According to Dr. Gooding, the test is accurate. She noted that there are 135 different strains of HPV. She noted that the test is specific as it provides users with a guideline of the type of HPV the person may have developed.
Meanwhile, Divisional Head of Health and Wellness of ANSA McAl Andrel Griffith said once the product hits the market, it would take 14 days before users receive their result. This is due to the fact that the kits will have to go overseas for testing.
This will be done though DHL. Guyana is likely to be the first English speaking Caribbean in which the system would be launched.
Mia by XYTRO test is a comprehensive diagnostic system developed and patented by the American company Mel-mont medical, LLC found 2014 by Frank Melendez, MSc and Liliana Montes, MSc.
Cervical cancer which is the second leading cancer to kill people in Guyana, but is the number one cause of cancer related deaths for women so with this form of HPV Testing which now the number one screening tool recommend for cervical cancer.